Drug Profile
Avicidin
Alternative Names: Avicidin-biotinLatest Information Update: 22 Nov 2000
Price :
$50
*
At a glance
- Originator Poniard Pharmaceuticals
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer; Lung cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer
Most Recent Events
- 22 Nov 2000 Discontinued-II for Breast cancer in USA (IV)
- 22 Nov 2000 Discontinued-II for Colorectal cancer in USA (IV)
- 22 Nov 2000 Discontinued-II for Lung cancer in USA (IV)